Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder. This Podcast is being Sponsored by LocumTenens.com
17 Loka 20244min
Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke
In this week's podcast, Neurology Today's editor-in-chief highlights articles on Eastern equine encephalitis relief, systems developed to meet demand for anti-amyloid therapies, and a new protocol for timely diagnosis and treatment for eye stroke in the emergency department. This Podcast is being Sponsored by LocumTenens.com
3 Loka 20244min
Brain circuit underlying placebo pain relief, common Parkinson's gene variants, blood biomarker testing for Alzheimer's
In this week's podcast, Neurology Today's editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson's gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer's.
19 Syys 20244min
Alzheimer's diagnosis criteria, AI and Parkinson's severity, neurotoxicity of racism
In this week's podcast, Neurology Today's editor-in-chief highlights a new workgroup's recommendations on biomarkers for diagnosing Alzheimer's, AI's ability to track Parkinson's severity from brief videos, and the latest research on how racism leads to neural changes and accelerated aging.
5 Syys 20245min
Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice
In this week's podcast, Neurology Today's editor-in-chief discusses data on the association between weight loss drugs and a rare type of optic neuropathy, ethical issues around normothermic regional perfusion, and how neurologists are onboarding and training advanced practice practitioners in comorbid cancer and stroke.
15 Elo 20245min
Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer
In this week's podcast, Neurology Today's editor-in-chief discusses data on the complex interaction between body composition, vascular health, and neurodegenerative disease, Tenecteplase in an extended treatment window and stroke-related disability, and gene expression in cormorbid cancer and stroke.
31 Heinä 20245min
Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab
In this week's podcast, Neurology Today's editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.
18 Heinä 20245min
Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology
In this week's podcast, Neurology Today's editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI's use in sleep neurology.
4 Heinä 20245min
